Cabaletta Bio, Inc (CABA) - Operating Margin

Corporate company logo of Cabaletta Bio Inc. (CABA)

Cabaletta Bio, Inc. (CABA) is a clinical-stage developer with no current sales, meaning its financial profile is based exclusively on R&D expenditures. The GURU.Markets operating margin curve contains a metric that settled at 0.00, reflecting a dependence on trial results and technological scalability. Patents for CABA-iREGT and stringent FDA safety controls for the therapy ensure a high barrier to entry.

cabalettabio.com (CABA): Operating Profitability from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for Cabaletta Bio (CABA)

- share price and consensus valuation forecast:
Fundamental valuation:Cabaletta Bio Inc., CABA
Brand item of cabalettabio.com

This indicator serves as a key filter for assessing cost management efficiency, measuring the share of operating profit in revenue before interest and taxes. Analyzing operating margin allows for the determination of a business's ability to generate cash flow from its core processes. For Cabaletta Bio, Inc. (CABA), this parameter reflects the cost of maintaining its R&D center, as high expenses for retaining elite bioinformaticians directly impact the dynamics of this metric.

Main competitors

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Margin KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operating Profit Margin|PVLA: Operating Sales Margin|Operating Profit Margin SVRA|RIGL: Operating Margin|Return on Sales by Operating Profit ANAB|ATXS (Astria Corp) - Operating Margin|Return on Sales by Operating Profit ENGN (enGene Bio)|Operating Margin RAPT|Profitability of Operations Aerovate Therapeutics|Operating Profitability Aclaris Therapeutics Inc. ACRS|Profitability of Operations Kyverna Therapeutics Inc. (KYTX)|TLSA - Operating Profitability|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com